Paulo C. Rodrı́guez
- Immunology top 0.05%
- Immune cells in cancer 50
- Immune Cell Function and Interaction 42
- Immunotherapy and Immune Responses 14
- Immune Response and Inflammation 12
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 11
- Biological Psychiatry top 1%
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 11
- Neurology top 1%
-
- Cancer Research and Treatments 11
- Co-authors
- Augusto C. OchoaJovanny ZabaletaDavid QuicenoArnold H. ZeaClaudia HernandezJuan B. OchoaSuzanne Ostrand‐RosenbergAmir A. Al-Khami
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesEgyptItaly
In The Last Decade
Paulo C. Rodrı́guez
117 papers receiving 15.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Immunology 10.6k
- Oncology 5.1k
- Biological Psychiatry 320
- Cancer Research 1.7k
- Neurology 701
Countries citing papers authored by Paulo C. Rodrı́guez
This map shows the geographic impact of Paulo C. Rodrı́guez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paulo C. Rodrı́guez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paulo C. Rodrı́guez more than expected).
Fields of papers citing papers by Paulo C. Rodrı́guez
This network shows the impact of papers produced by Paulo C. Rodrı́guez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paulo C. Rodrı́guez. The network helps show where Paulo C. Rodrı́guez may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paulo C. Rodrı́guez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 96 | |
| 6 | 2021 | 19 | |
| 7 | 2017 | 87 | |
| 8 | 2017 | 61 | |
| 9 | 2017 | 27 | |
| 10 | 2017 | 60 | |
| 11 | 2017 | 64 | |
| 12 | 2014 | 219 | |
| 13 | 2014 | 66 | |
| 14 | 2013 | 55 | |
| 15 | 2013 | 54 | |
| 16 | 2013 | 37 | |
| 17 | Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteinebreakdown → | 2009 | 759 |
| 18 | 2009 | 216 | |
| 19 | Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytesbreakdown → | 2009 | 634 |
| 20 | Arginase-Producing Myeloid Suppressor Cells in Renal Cell Carcinoma Patients: A Mechanism of Tumor Evasionbreakdown → | 2005 | 671 |
About Paulo C. Rodrı́guez
Paulo C. Rodrı́guez is a scholar working on Immunology, Physiology and Biochemistry, having authored 124 papers that have together received 15.2k indexed citations. Recurring topics across this work include Immune cells in cancer (50 papers), Immune Cell Function and Interaction (42 papers), Cancer Immunotherapy and Biomarkers (15 papers), Immunotherapy and Immune Responses (14 papers), Immune Response and Inflammation (12 papers), Cancer Research and Treatments (11 papers), CAR-T cell therapy research (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Immunology (10.6k citations), Oncology (5.1k citations) and Biological Psychiatry (320 citations). Paulo C. Rodrı́guez has collaborated with scholars based in United States, Egypt and Italy. Frequent co-authors include Augusto C. Ochoa, Jovanny Zabaleta, David Quiceno, Arnold H. Zea, Claudia Hernandez, Juan B. Ochoa, Suzanne Ostrand‐Rosenberg, Amir A. Al-Khami, Rosa A. Sierra and Patrick Raber. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.